Cabergoline
- 1 lab
- Animals1
Outcomes
4T cell exhaustion
downin mice1
1 study
T cell exhaustion
downin mice1
Cabergoline decreases T cell exhaustion in mice.
“reducing ductal area and proliferation, and reversing T cell exhaustion”
Animalspost-lactation treatment in K14-Cre; Brca1F/F, Trp53F/F micemammary glandsingle dose
Cancer discovery15 Oct 2026
Mammary gland involution
upin mice1
1 study
Mammary gland involution
upin mice1
Cabergoline increases mammary gland involution in mice.
“cabergoline treatment remodels the mammary gland by potentiating involution”
Animalspost-lactation treatment in K14-Cre; Brca1F/F, Trp53F/F micemammary glandsingle dose
Cancer discovery15 Oct 2026
Time to postpartum mammary cancer onset
upin mice1
1 study
Time to postpartum mammary cancer onset
upin mice1
Cabergoline increases time to postpartum mammary cancer onset in mice.
“delays the onset and reduces the incidence of postpartum mammary cancer in K14-Cre; Brca1F/F, Trp53F/F mice.”
Animalspost-lactation treatment in K14-Cre; Brca1F/F, Trp53F/F micemammary glandsingle dose
Cancer discovery15 Oct 2026
Postpartum mammary cancer incidence
downin mice1
1 study
Postpartum mammary cancer incidence
downin mice1
Cabergoline decreases postpartum mammary cancer incidence in mice.
“delays the onset and reduces the incidence of postpartum mammary cancer in K14-Cre; Brca1F/F, Trp53F/F mice.”
Animalspost-lactation treatment in K14-Cre; Brca1F/F, Trp53F/F micemammary glandsingle dose
Cancer discovery15 Oct 2026
Associations
1Postpartum breast cancer incidence
downin humans1−69% lower risk
1 study
Postpartum breast cancer incidence
downin humans1−69% lower risk
Cabergoline is associated with postpartum breast cancer incidence in humans (approximately 69% lower risk).
“cabergoline treatment was associated with a lower incidence of postpartum breast cancer, with a meta-analysis indicating an approximate 69% reduction in risk.”
Humanstwo independent retrospective cohorts of European women; pooled associationbreastfemales
Cancer discovery15 Oct 2026